Sally Stabler
Concepts (824)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin B 12 Deficiency | 62 | 2020 | 78 | 6.680 |
Why?
| | Vitamin B 12 | 60 | 2020 | 127 | 5.710 |
Why?
| | Homocysteine | 79 | 2024 | 152 | 5.110 |
Why?
| | Homocystinuria | 18 | 2024 | 62 | 3.630 |
Why?
| | Folic Acid | 53 | 2026 | 198 | 3.250 |
Why?
| | Methionine | 40 | 2021 | 162 | 2.940 |
Why?
| | Methylmalonic Acid | 54 | 2017 | 66 | 2.850 |
Why?
| | Folic Acid Deficiency | 27 | 2021 | 49 | 2.640 |
Why?
| | Cystathionine beta-Synthase | 17 | 2024 | 65 | 2.110 |
Why?
| | Liver | 29 | 2024 | 1895 | 1.990 |
Why?
| | Betaine | 19 | 2024 | 67 | 1.890 |
Why?
| | S-Adenosylmethionine | 22 | 2020 | 59 | 1.710 |
Why?
| | S-Adenosylhomocysteine | 17 | 2020 | 24 | 1.690 |
Why?
| | Hyperhomocysteinemia | 14 | 2020 | 27 | 1.560 |
Why?
| | Vitamin B Complex | 10 | 2020 | 40 | 1.510 |
Why?
| | Amino Acids, Sulfur | 4 | 2020 | 8 | 1.350 |
Why?
| | Nutritional Status | 8 | 2020 | 352 | 1.020 |
Why?
| | Cysteine | 12 | 2020 | 208 | 1.010 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 3 | 2019 | 9 | 0.940 |
Why?
| | Taurine | 4 | 2019 | 41 | 0.940 |
Why?
| | Tetrahydrofolates | 2 | 2024 | 16 | 0.910 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.840 |
Why?
| | Sulfur | 3 | 2020 | 64 | 0.740 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 9 | 2021 | 35 | 0.710 |
Why?
| | Oxidation-Reduction | 5 | 2024 | 1080 | 0.710 |
Why?
| | Choline | 11 | 2017 | 137 | 0.690 |
Why?
| | Dietary Supplements | 15 | 2020 | 580 | 0.680 |
Why?
| | Sulfur Compounds | 1 | 2020 | 7 | 0.650 |
Why?
| | Methionine Adenosyltransferase | 6 | 2020 | 10 | 0.650 |
Why?
| | Metabolic Diseases | 1 | 2020 | 114 | 0.590 |
Why?
| | Glycine Hydroxymethyltransferase | 7 | 2026 | 16 | 0.590 |
Why?
| | Anemia | 6 | 2014 | 190 | 0.580 |
Why?
| | Neural Tube Defects | 5 | 2026 | 67 | 0.580 |
Why?
| | Anemia, Megaloblastic | 6 | 2020 | 9 | 0.490 |
Why?
| | Methylation | 12 | 2020 | 242 | 0.490 |
Why?
| | Cystathionine | 14 | 2012 | 22 | 0.480 |
Why?
| | Diet | 12 | 2013 | 1280 | 0.460 |
Why?
| | Animals | 67 | 2026 | 38141 | 0.460 |
Why?
| | Humans | 163 | 2021 | 145491 | 0.440 |
Why?
| | Iron, Dietary | 1 | 2014 | 23 | 0.430 |
Why?
| | Female | 120 | 2026 | 78763 | 0.430 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2014 | 62 | 0.420 |
Why?
| | Adenosylhomocysteinase | 5 | 2021 | 9 | 0.420 |
Why?
| | Mice | 35 | 2026 | 18338 | 0.410 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 4 | 2017 | 18 | 0.410 |
Why?
| | Aged, 80 and over | 34 | 2017 | 8326 | 0.400 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 4 | 2015 | 25 | 0.400 |
Why?
| | Gas Chromatography-Mass Spectrometry | 16 | 2020 | 127 | 0.400 |
Why?
| | Glutathione | 8 | 2020 | 366 | 0.390 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4559 | 0.380 |
Why?
| | Male | 104 | 2026 | 72817 | 0.370 |
Why?
| | Cognition Disorders | 5 | 2011 | 541 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 11 | 2020 | 2030 | 0.330 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 4 | 2017 | 8 | 0.330 |
Why?
| | Isoenzymes | 5 | 2012 | 297 | 0.330 |
Why?
| | Frail Elderly | 2 | 2010 | 136 | 0.330 |
Why?
| | Aged | 59 | 2017 | 26125 | 0.320 |
Why?
| | Biomarkers | 19 | 2020 | 4283 | 0.320 |
Why?
| | Metabolism, Inborn Errors | 5 | 2020 | 42 | 0.320 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 48 | 0.310 |
Why?
| | Receptors, Cell Surface | 3 | 2015 | 372 | 0.310 |
Why?
| | Carbon | 3 | 2024 | 204 | 0.310 |
Why?
| | Uracil | 4 | 2021 | 36 | 0.310 |
Why?
| | Methylmalonyl-CoA Mutase | 9 | 2017 | 11 | 0.310 |
Why?
| | Cystathionine gamma-Lyase | 4 | 2020 | 13 | 0.300 |
Why?
| | Thioctic Acid | 1 | 2009 | 12 | 0.300 |
Why?
| | Thrombosis | 2 | 2011 | 401 | 0.300 |
Why?
| | Abortion, Spontaneous | 1 | 2009 | 117 | 0.290 |
Why?
| | Middle Aged | 57 | 2020 | 36176 | 0.280 |
Why?
| | Vitamin B Deficiency | 1 | 2008 | 1 | 0.280 |
Why?
| | Eubacterium | 1 | 2008 | 3 | 0.280 |
Why?
| | Propionibacterium | 1 | 2008 | 3 | 0.280 |
Why?
| | DNA | 8 | 2020 | 1451 | 0.280 |
Why?
| | Intestinal Absorption | 3 | 2013 | 103 | 0.280 |
Why?
| | Adult | 69 | 2020 | 40707 | 0.280 |
Why?
| | Up-Regulation | 3 | 2017 | 848 | 0.270 |
Why?
| | Feces | 3 | 2019 | 514 | 0.260 |
Why?
| | Acyl Coenzyme A | 5 | 2006 | 32 | 0.260 |
Why?
| | Pregnancy | 17 | 2020 | 7197 | 0.260 |
Why?
| | Diabetic Neuropathies | 2 | 2026 | 99 | 0.250 |
Why?
| | Malnutrition | 1 | 2008 | 86 | 0.250 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2026 | 134 | 0.250 |
Why?
| | Mice, Knockout | 11 | 2026 | 3125 | 0.250 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 5989 | 0.250 |
Why?
| | Dietary Services | 2 | 2005 | 2 | 0.250 |
Why?
| | Prevalence | 13 | 2017 | 2855 | 0.240 |
Why?
| | Corrinoids | 2 | 2019 | 7 | 0.240 |
Why?
| | Nutrition Assessment | 1 | 2006 | 92 | 0.240 |
Why?
| | Sulfhydryl Compounds | 4 | 2018 | 188 | 0.240 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2021 | 268 | 0.230 |
Why?
| | Antioxidants | 1 | 2009 | 549 | 0.230 |
Why?
| | Amino Acids | 6 | 2020 | 521 | 0.230 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 7 | 2017 | 18 | 0.230 |
Why?
| | Human papillomavirus 16 | 2 | 2018 | 27 | 0.220 |
Why?
| | Transcobalamins | 3 | 2017 | 3 | 0.220 |
Why?
| | Disease Progression | 3 | 2011 | 2862 | 0.220 |
Why?
| | Vitamin B 6 | 2 | 2003 | 11 | 0.210 |
Why?
| | Geriatrics | 2 | 2003 | 95 | 0.210 |
Why?
| | Administration, Oral | 8 | 2019 | 863 | 0.200 |
Why?
| | Brain Diseases | 2 | 2020 | 153 | 0.200 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 978 | 0.200 |
Why?
| | Mutation | 11 | 2017 | 4093 | 0.200 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2015 | 178 | 0.200 |
Why?
| | Rumen | 3 | 2014 | 8 | 0.200 |
Why?
| | Food, Fortified | 4 | 2010 | 44 | 0.200 |
Why?
| | Gestational Age | 3 | 2020 | 988 | 0.200 |
Why?
| | Rats | 18 | 2016 | 5581 | 0.190 |
Why?
| | Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2012 | 2 | 0.190 |
Why?
| | Uterine Artery | 2 | 2020 | 74 | 0.190 |
Why?
| | Apolipoproteins E | 5 | 2013 | 94 | 0.190 |
Why?
| | Fetal Blood | 5 | 2013 | 325 | 0.180 |
Why?
| | Neonatal Screening | 2 | 2007 | 179 | 0.180 |
Why?
| | Hearing Loss | 1 | 2006 | 249 | 0.180 |
Why?
| | Ferredoxin-NADP Reductase | 3 | 2012 | 3 | 0.180 |
Why?
| | Heterozygote | 4 | 2015 | 313 | 0.170 |
Why?
| | Cohort Studies | 11 | 2020 | 5992 | 0.170 |
Why?
| | Nutrition Surveys | 3 | 2011 | 280 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2015 | 187 | 0.170 |
Why?
| | Mice, Transgenic | 8 | 2014 | 2189 | 0.170 |
Why?
| | Body Mass Index | 1 | 2009 | 2425 | 0.170 |
Why?
| | Lactation | 4 | 2015 | 193 | 0.170 |
Why?
| | Cattle | 3 | 2014 | 977 | 0.160 |
Why?
| | Sulfites | 1 | 2020 | 8 | 0.160 |
Why?
| | Polyamines | 1 | 2021 | 41 | 0.160 |
Why?
| | Formate-Tetrahydrofolate Ligase | 2 | 2012 | 2 | 0.160 |
Why?
| | Anemia, Pernicious | 3 | 2013 | 6 | 0.160 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2011 | 98 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 455 | 0.160 |
Why?
| | Fetal Growth Retardation | 2 | 2020 | 593 | 0.160 |
Why?
| | Brazil | 4 | 2009 | 183 | 0.160 |
Why?
| | Aging | 7 | 2010 | 1940 | 0.160 |
Why?
| | Global Health | 1 | 2004 | 404 | 0.160 |
Why?
| | Carrier Proteins | 3 | 2014 | 733 | 0.160 |
Why?
| | Animals, Newborn | 3 | 2007 | 890 | 0.160 |
Why?
| | Polymorphism, Genetic | 4 | 2015 | 616 | 0.150 |
Why?
| | Virus Integration | 2 | 2018 | 69 | 0.150 |
Why?
| | Reference Values | 12 | 2010 | 797 | 0.150 |
Why?
| | Aminobutyrates | 2 | 2018 | 31 | 0.150 |
Why?
| | Erythrocytes | 8 | 2011 | 751 | 0.150 |
Why?
| | Genetic Diseases, Inborn | 2 | 2004 | 45 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Caenorhabditis elegans | 2 | 2017 | 326 | 0.150 |
Why?
| | Depressive Disorder | 2 | 2000 | 387 | 0.150 |
Why?
| | Gene Rearrangement | 1 | 2020 | 156 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Isomerases | 3 | 1988 | 8 | 0.140 |
Why?
| | Carnitine | 2 | 1990 | 91 | 0.140 |
Why?
| | Vitamin B 6 Deficiency | 3 | 2011 | 6 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2026 | 2582 | 0.140 |
Why?
| | Infant, Newborn | 14 | 2020 | 6437 | 0.140 |
Why?
| | Sarcosine | 6 | 2012 | 10 | 0.140 |
Why?
| | Homozygote | 2 | 2015 | 200 | 0.140 |
Why?
| | Genotype | 8 | 2015 | 1853 | 0.140 |
Why?
| | Hemophilia B | 2 | 2003 | 65 | 0.140 |
Why?
| | Chromatography, Liquid | 4 | 2011 | 445 | 0.140 |
Why?
| | Liver Diseases | 2 | 2020 | 304 | 0.140 |
Why?
| | Risk Factors | 15 | 2017 | 10874 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1212 | 0.140 |
Why?
| | Sulfinic Acids | 1 | 2018 | 6 | 0.140 |
Why?
| | Adolescent | 28 | 2020 | 22485 | 0.130 |
Why?
| | Georgia | 5 | 2013 | 79 | 0.130 |
Why?
| | Mass Spectrometry | 4 | 2017 | 744 | 0.130 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 20 | 0.130 |
Why?
| | Infant | 14 | 2015 | 10064 | 0.130 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
| | Young Adult | 17 | 2020 | 14192 | 0.130 |
Why?
| | Geriatric Assessment | 4 | 2013 | 238 | 0.130 |
Why?
| | Racemases and Epimerases | 2 | 2006 | 11 | 0.130 |
Why?
| | Genetic Variation | 2 | 2015 | 988 | 0.130 |
Why?
| | Phosphatidylcholines | 5 | 2013 | 130 | 0.130 |
Why?
| | Lymphoma, AIDS-Related | 2 | 1996 | 14 | 0.130 |
Why?
| | Thymidine Monophosphate | 3 | 2013 | 4 | 0.130 |
Why?
| | Folate Receptor 2 | 1 | 2017 | 7 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2017 | 118 | 0.130 |
Why?
| | Methyltransferases | 5 | 2008 | 75 | 0.120 |
Why?
| | DNA, Mitochondrial | 3 | 2021 | 212 | 0.120 |
Why?
| | ROC Curve | 2 | 2011 | 619 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2015 | 2146 | 0.120 |
Why?
| | Child, Preschool | 17 | 2020 | 11837 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 536 | 0.120 |
Why?
| | Hematinics | 2 | 2006 | 22 | 0.120 |
Why?
| | Carcinogenesis | 1 | 2018 | 227 | 0.120 |
Why?
| | Crosses, Genetic | 2 | 2013 | 125 | 0.120 |
Why?
| | Propionates | 3 | 2017 | 38 | 0.120 |
Why?
| | Thromboembolism | 2 | 2015 | 128 | 0.120 |
Why?
| | Lung | 5 | 2012 | 4103 | 0.120 |
Why?
| | Diabetic Nephropathies | 1 | 1999 | 318 | 0.110 |
Why?
| | Stomach | 1 | 1996 | 111 | 0.110 |
Why?
| | Alleles | 5 | 2009 | 893 | 0.110 |
Why?
| | Hydroxocobalamin | 3 | 1990 | 33 | 0.110 |
Why?
| | Genome | 1 | 2018 | 305 | 0.110 |
Why?
| | Linear Models | 5 | 2010 | 848 | 0.110 |
Why?
| | Neoplasms, Experimental | 2 | 2017 | 168 | 0.110 |
Why?
| | Phospholipids | 1 | 2017 | 216 | 0.110 |
Why?
| | Glycine N-Methyltransferase | 3 | 2011 | 4 | 0.110 |
Why?
| | Keratinocytes | 2 | 2018 | 250 | 0.110 |
Why?
| | Weight Gain | 2 | 2016 | 557 | 0.110 |
Why?
| | Alcoholism | 2 | 2020 | 821 | 0.110 |
Why?
| | Age Factors | 6 | 2010 | 3340 | 0.110 |
Why?
| | Thymidylate Synthase | 2 | 2011 | 13 | 0.110 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 600 | 0.110 |
Why?
| | Double-Blind Method | 7 | 2015 | 2060 | 0.110 |
Why?
| | Choline Deficiency | 3 | 2012 | 10 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.110 |
Why?
| | Hemophilia A | 2 | 1996 | 147 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 15 | 0.110 |
Why?
| | Pilot Projects | 3 | 2020 | 1896 | 0.110 |
Why?
| | DNA Methylation | 4 | 2018 | 667 | 0.110 |
Why?
| | RNA, Messenger | 6 | 2017 | 2820 | 0.110 |
Why?
| | Milk, Human | 2 | 2015 | 174 | 0.110 |
Why?
| | Dietary Fats | 1 | 2016 | 308 | 0.110 |
Why?
| | Micronutrients | 1 | 2015 | 102 | 0.110 |
Why?
| | Hemoglobins, Abnormal | 1 | 1994 | 8 | 0.100 |
Why?
| | Placenta | 3 | 2017 | 784 | 0.100 |
Why?
| | Energy Intake | 2 | 2015 | 506 | 0.100 |
Why?
| | Cyanosis | 1 | 1994 | 18 | 0.100 |
Why?
| | Child | 16 | 2020 | 22680 | 0.100 |
Why?
| | Blotting, Western | 5 | 2014 | 1162 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 907 | 0.100 |
Why?
| | Milk | 1 | 2014 | 119 | 0.100 |
Why?
| | Paresthesia | 2 | 2013 | 14 | 0.100 |
Why?
| | Cross-Sectional Studies | 7 | 2010 | 5891 | 0.100 |
Why?
| | Colitis | 2 | 2019 | 280 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 686 | 0.100 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 237 | 0.100 |
Why?
| | Women's Health | 3 | 2015 | 308 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2014 | 187 | 0.100 |
Why?
| | Infant Nutrition Disorders | 1 | 2013 | 10 | 0.100 |
Why?
| | Child Nutrition Disorders | 1 | 2013 | 20 | 0.100 |
Why?
| | Analysis of Variance | 5 | 2011 | 1304 | 0.090 |
Why?
| | Time Factors | 7 | 2006 | 7171 | 0.090 |
Why?
| | Malonates | 3 | 1990 | 8 | 0.090 |
Why?
| | Lipid Metabolism | 1 | 2016 | 529 | 0.090 |
Why?
| | Interleukin-1beta | 2 | 2011 | 390 | 0.090 |
Why?
| | Chloroflexi | 1 | 2012 | 12 | 0.090 |
Why?
| | Maternal-Fetal Exchange | 1 | 2013 | 170 | 0.090 |
Why?
| | Apolipoproteins A | 1 | 2012 | 19 | 0.090 |
Why?
| | DNA Mutational Analysis | 3 | 2009 | 409 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2594 | 0.090 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 17 | 0.090 |
Why?
| | Aminohydrolases | 1 | 2012 | 4 | 0.090 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 23 | 0.090 |
Why?
| | Papillomavirus Infections | 2 | 2018 | 343 | 0.090 |
Why?
| | Injections | 1 | 2013 | 200 | 0.090 |
Why?
| | Apolipoprotein A-I | 1 | 2012 | 39 | 0.090 |
Why?
| | Hemoglobins | 3 | 2011 | 386 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2011 | 974 | 0.090 |
Why?
| | Multienzyme Complexes | 1 | 2012 | 65 | 0.090 |
Why?
| | Bone Density | 1 | 2015 | 484 | 0.090 |
Why?
| | Pyridoxine | 3 | 1996 | 37 | 0.090 |
Why?
| | Logistic Models | 4 | 2013 | 2130 | 0.090 |
Why?
| | Fibroblasts | 6 | 2021 | 1023 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2013 | 179 | 0.090 |
Why?
| | Prospective Studies | 12 | 2013 | 8039 | 0.090 |
Why?
| | Neurogenesis | 1 | 2013 | 157 | 0.080 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 314 | 0.080 |
Why?
| | Vitamins | 3 | 2007 | 180 | 0.080 |
Why?
| | Oxidative Stress | 4 | 2019 | 1350 | 0.080 |
Why?
| | Superoxide Dismutase | 1 | 1993 | 303 | 0.080 |
Why?
| | Cell Nucleus | 2 | 2011 | 593 | 0.080 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2011 | 161 | 0.080 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2008 | 63 | 0.080 |
Why?
| | Mutation, Missense | 4 | 2009 | 338 | 0.080 |
Why?
| | Hydrops Fetalis | 1 | 2010 | 13 | 0.080 |
Why?
| | Nutritional Requirements | 2 | 2010 | 78 | 0.080 |
Why?
| | Memory | 1 | 2013 | 297 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 975 | 0.080 |
Why?
| | Cognition | 2 | 2013 | 1268 | 0.080 |
Why?
| | Cell Line | 4 | 2017 | 2823 | 0.080 |
Why?
| | Inflammation | 3 | 2019 | 2883 | 0.080 |
Why?
| | Polymerase Chain Reaction | 3 | 2009 | 1049 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 2009 | 612 | 0.080 |
Why?
| | Coenzyme A | 1 | 1990 | 8 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 2002 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 218 | 0.080 |
Why?
| | Lactams | 1 | 1990 | 28 | 0.080 |
Why?
| | RNA-Binding Proteins | 3 | 2017 | 461 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 264 | 0.080 |
Why?
| | Creatinine | 4 | 2011 | 513 | 0.080 |
Why?
| | Hematocrit | 4 | 2002 | 108 | 0.080 |
Why?
| | Mice, Nude | 3 | 2018 | 678 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1332 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 271 | 0.080 |
Why?
| | Siblings | 1 | 2010 | 195 | 0.080 |
Why?
| | Leukocytes | 2 | 2015 | 295 | 0.070 |
Why?
| | Educational Status | 2 | 2003 | 465 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 262 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2006 | 951 | 0.070 |
Why?
| | Gastrointestinal Contents | 1 | 2009 | 8 | 0.070 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1487 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2010 | 147 | 0.070 |
Why?
| | Treatment Outcome | 8 | 2013 | 11831 | 0.070 |
Why?
| | Kidney | 2 | 2007 | 1498 | 0.070 |
Why?
| | Formates | 1 | 2008 | 15 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 410 | 0.070 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2008 | 8 | 0.070 |
Why?
| | Neuropsychological Tests | 3 | 2013 | 1139 | 0.070 |
Why?
| | Reduced Folate Carrier Protein | 1 | 2008 | 9 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 691 | 0.070 |
Why?
| | Deuterium | 3 | 2015 | 100 | 0.070 |
Why?
| | Amino Acid Isomerases | 1 | 1988 | 1 | 0.070 |
Why?
| | Intramolecular Transferases | 1 | 1988 | 3 | 0.070 |
Why?
| | Homeostasis | 2 | 2020 | 639 | 0.070 |
Why?
| | Fatty Liver | 2 | 2010 | 254 | 0.070 |
Why?
| | Biological Availability | 2 | 2010 | 144 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2185 | 0.070 |
Why?
| | Recurrence | 1 | 2011 | 1142 | 0.070 |
Why?
| | Parity | 1 | 2008 | 109 | 0.070 |
Why?
| | Leucine | 1 | 1988 | 116 | 0.070 |
Why?
| | Cytoplasm | 1 | 2008 | 257 | 0.070 |
Why?
| | Folate Receptors, GPI-Anchored | 2 | 2005 | 5 | 0.070 |
Why?
| | Oxygen | 1 | 1993 | 986 | 0.070 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2007 | 56 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1247 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2009 | 2526 | 0.060 |
Why?
| | Socioeconomic Factors | 3 | 2008 | 1327 | 0.060 |
Why?
| | Hippocampus | 1 | 2013 | 969 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 1001 | 0.060 |
Why?
| | Lipids | 1 | 2012 | 709 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2012 | 2910 | 0.060 |
Why?
| | Cobalt | 3 | 2014 | 52 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3076 | 0.060 |
Why?
| | Muscle, Skeletal | 2 | 2007 | 1794 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 2 | 2020 | 118 | 0.060 |
Why?
| | Base Sequence | 4 | 2015 | 2180 | 0.060 |
Why?
| | Succinates | 4 | 1991 | 24 | 0.060 |
Why?
| | Fibrinogens, Abnormal | 1 | 2006 | 2 | 0.060 |
Why?
| | Thrombin Time | 1 | 2006 | 11 | 0.060 |
Why?
| | Smoking | 2 | 2012 | 1468 | 0.060 |
Why?
| | Afibrinogenemia | 1 | 2006 | 8 | 0.060 |
Why?
| | Succinic Acid | 4 | 1991 | 46 | 0.060 |
Why?
| | Diagnosis, Differential | 4 | 2006 | 1507 | 0.060 |
Why?
| | Cardiotonic Agents | 1 | 2006 | 94 | 0.060 |
Why?
| | Iron | 2 | 2008 | 359 | 0.060 |
Why?
| | Cobamides | 1 | 2006 | 25 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 207 | 0.060 |
Why?
| | Social Class | 2 | 2005 | 265 | 0.060 |
Why?
| | Mitochondria | 3 | 2021 | 990 | 0.060 |
Why?
| | Homocystine | 1 | 2005 | 1 | 0.060 |
Why?
| | Dextran Sulfate | 2 | 2019 | 93 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 1999 | 237 | 0.060 |
Why?
| | Oncogene Proteins, Viral | 2 | 2018 | 20 | 0.060 |
Why?
| | von Willebrand Factor | 2 | 2006 | 85 | 0.060 |
Why?
| | Severity of Illness Index | 5 | 2011 | 2945 | 0.060 |
Why?
| | Ganglia, Spinal | 1 | 2026 | 89 | 0.060 |
Why?
| | Disulfides | 2 | 2008 | 94 | 0.060 |
Why?
| | Recommended Dietary Allowances | 2 | 2015 | 16 | 0.060 |
Why?
| | Acidosis | 1 | 2006 | 105 | 0.060 |
Why?
| | Transfection | 2 | 2006 | 925 | 0.060 |
Why?
| | Brain Edema | 2 | 2003 | 62 | 0.060 |
Why?
| | Fetus | 2 | 2012 | 804 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2011 | 1164 | 0.050 |
Why?
| | Food Services | 1 | 2005 | 21 | 0.050 |
Why?
| | Apoptosis | 2 | 2012 | 2411 | 0.050 |
Why?
| | Zinc | 1 | 2008 | 297 | 0.050 |
Why?
| | Kidney Diseases | 2 | 2007 | 427 | 0.050 |
Why?
| | Epidemiologic Methods | 1 | 2005 | 91 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1585 | 0.050 |
Why?
| | Hyperoxia | 1 | 2005 | 96 | 0.050 |
Why?
| | Gene Expression | 3 | 2018 | 1478 | 0.050 |
Why?
| | Mass Screening | 3 | 2002 | 1358 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1321 | 0.050 |
Why?
| | Diet, Vegetarian | 1 | 2004 | 10 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2018 | 269 | 0.050 |
Why?
| | Indicator Dilution Techniques | 1 | 2003 | 12 | 0.050 |
Why?
| | Carotid Stenosis | 1 | 2005 | 107 | 0.050 |
Why?
| | Liver Cirrhosis | 2 | 2010 | 287 | 0.050 |
Why?
| | Menopause | 1 | 2007 | 319 | 0.050 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2006 | 207 | 0.050 |
Why?
| | Brain | 5 | 2012 | 2944 | 0.050 |
Why?
| | 5' Untranslated Regions | 1 | 2004 | 59 | 0.050 |
Why?
| | Arginine | 1 | 2005 | 238 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 675 | 0.050 |
Why?
| | Fasting | 5 | 2004 | 275 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 161 | 0.050 |
Why?
| | Hemorrhage | 2 | 2006 | 826 | 0.050 |
Why?
| | Sex Factors | 3 | 2010 | 2110 | 0.050 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2008 | 437 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2008 | 1112 | 0.050 |
Why?
| | Testosterone | 1 | 2007 | 413 | 0.050 |
Why?
| | Postoperative Complications | 1 | 1996 | 2962 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2897 | 0.050 |
Why?
| | Factor IX | 1 | 2003 | 49 | 0.050 |
Why?
| | Mental Disorders | 3 | 1998 | 1157 | 0.050 |
Why?
| | Nutritional Support | 1 | 2003 | 39 | 0.050 |
Why?
| | Protein Binding | 2 | 2012 | 2250 | 0.050 |
Why?
| | Infant Food | 1 | 2003 | 69 | 0.050 |
Why?
| | Kinetics | 6 | 2007 | 1605 | 0.050 |
Why?
| | Smoke | 1 | 2004 | 148 | 0.050 |
Why?
| | Lyases | 1 | 2002 | 16 | 0.050 |
Why?
| | Connective Tissue | 1 | 2002 | 39 | 0.050 |
Why?
| | Mutagenesis, Insertional | 2 | 2012 | 68 | 0.050 |
Why?
| | Brachial Artery | 2 | 2019 | 208 | 0.050 |
Why?
| | Glutamates | 1 | 2002 | 66 | 0.040 |
Why?
| | HeLa Cells | 1 | 2004 | 633 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 302 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2005 | 3537 | 0.040 |
Why?
| | Guanine | 1 | 2002 | 85 | 0.040 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 14 | 0.040 |
Why?
| | Metalloendopeptidases | 1 | 2001 | 63 | 0.040 |
Why?
| | Phenotype | 4 | 2014 | 3157 | 0.040 |
Why?
| | Pyridoxal Phosphate | 2 | 2011 | 25 | 0.040 |
Why?
| | Vascular Diseases | 3 | 2004 | 252 | 0.040 |
Why?
| | Methotrexate | 2 | 2015 | 232 | 0.040 |
Why?
| | Down-Regulation | 1 | 2004 | 616 | 0.040 |
Why?
| | Birth Weight | 1 | 2004 | 511 | 0.040 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 6070 | 0.040 |
Why?
| | Molecular Weight | 5 | 1988 | 312 | 0.040 |
Why?
| | Malonyl Coenzyme A | 3 | 1990 | 5 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 206 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2000 | 7 | 0.040 |
Why?
| | New York | 2 | 2015 | 127 | 0.040 |
Why?
| | Papio | 1 | 2000 | 69 | 0.040 |
Why?
| | Citrates | 3 | 1998 | 40 | 0.040 |
Why?
| | Antigens, CD | 2 | 2001 | 557 | 0.040 |
Why?
| | Anemia, Macrocytic | 1 | 2000 | 4 | 0.040 |
Why?
| | Models, Biological | 4 | 2012 | 1815 | 0.040 |
Why?
| | Case-Control Studies | 5 | 2010 | 3619 | 0.040 |
Why?
| | Pregnancy Outcome | 2 | 2020 | 497 | 0.040 |
Why?
| | Neurocognitive Disorders | 2 | 1992 | 33 | 0.040 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2000 | 87 | 0.040 |
Why?
| | Sampling Studies | 1 | 2000 | 98 | 0.040 |
Why?
| | Coronary Artery Disease | 1 | 2006 | 760 | 0.040 |
Why?
| | Genetic Testing | 1 | 2003 | 480 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1994 | 581 | 0.040 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2001 | 279 | 0.040 |
Why?
| | Odds Ratio | 3 | 2002 | 1082 | 0.040 |
Why?
| | Oncogenes | 1 | 2020 | 118 | 0.040 |
Why?
| | Parenteral Nutrition | 1 | 2000 | 102 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1367 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 234 | 0.040 |
Why?
| | Blotting, Northern | 3 | 2007 | 203 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 1996 | 287 | 0.040 |
Why?
| | Cecum | 1 | 2019 | 37 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Species Specificity | 2 | 2007 | 573 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2003 | 441 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 1999 | 156 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 117 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 325 | 0.040 |
Why?
| | Reticulocyte Count | 2 | 2000 | 7 | 0.040 |
Why?
| | Pancytopenia | 1 | 1999 | 7 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2019 | 60 | 0.040 |
Why?
| | Stroke | 2 | 2005 | 1272 | 0.040 |
Why?
| | Metabolomics | 2 | 2017 | 729 | 0.030 |
Why?
| | Income | 1 | 1999 | 201 | 0.030 |
Why?
| | RNA | 2 | 2004 | 929 | 0.030 |
Why?
| | Albuminuria | 1 | 1999 | 190 | 0.030 |
Why?
| | Nutrition Policy | 2 | 2010 | 58 | 0.030 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 11 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2000 | 255 | 0.030 |
Why?
| | Oligodendroglia | 1 | 2000 | 190 | 0.030 |
Why?
| | Cross-Over Studies | 2 | 2014 | 607 | 0.030 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 364 | 0.030 |
Why?
| | Pedigree | 2 | 2001 | 515 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 294 | 0.030 |
Why?
| | Tissue Distribution | 2 | 2011 | 335 | 0.030 |
Why?
| | Exons | 2 | 2011 | 363 | 0.030 |
Why?
| | Central Nervous System Diseases | 1 | 1998 | 74 | 0.030 |
Why?
| | Aspartate Aminotransferases | 2 | 2011 | 85 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 128 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2010 | 137 | 0.030 |
Why?
| | Cytosol | 1 | 2017 | 214 | 0.030 |
Why?
| | History, 20th Century | 2 | 2015 | 327 | 0.030 |
Why?
| | Alanine Transaminase | 2 | 2011 | 151 | 0.030 |
Why?
| | Angina Pectoris | 1 | 1997 | 75 | 0.030 |
Why?
| | Alcohol Drinking | 2 | 2001 | 837 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2016 | 36 | 0.030 |
Why?
| | Chronic Disease | 2 | 2011 | 1816 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2005 | 762 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 422 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2000 | 113 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2010 | 306 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2001 | 908 | 0.030 |
Why?
| | United States | 3 | 2020 | 16115 | 0.030 |
Why?
| | Denmark | 1 | 2015 | 50 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2012 | 4127 | 0.030 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 765 | 0.030 |
Why?
| | Sulfaquinoxaline | 1 | 2015 | 1 | 0.030 |
Why?
| | Food, Formulated | 1 | 2015 | 16 | 0.030 |
Why?
| | Body Weight | 2 | 2011 | 970 | 0.030 |
Why?
| | Carbon Cycle | 1 | 2015 | 14 | 0.030 |
Why?
| | Hematologic Diseases | 1 | 1996 | 66 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 375 | 0.030 |
Why?
| | HIV Infections | 2 | 2001 | 3189 | 0.030 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1996 | 124 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2015 | 88 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 5 | 2006 | 3897 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1659 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 1995 | 83 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2499 | 0.030 |
Why?
| | Hyaline Membrane Disease | 1 | 1994 | 20 | 0.030 |
Why?
| | Omasum | 1 | 2014 | 2 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 1997 | 271 | 0.030 |
Why?
| | Histones | 1 | 2020 | 663 | 0.030 |
Why?
| | Parenteral Nutrition, Total | 1 | 1994 | 30 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2015 | 68 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 299 | 0.030 |
Why?
| | Family Health | 2 | 2006 | 191 | 0.030 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.030 |
Why?
| | Fermentation | 1 | 2014 | 32 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 40 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2018 | 430 | 0.030 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 10 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 218 | 0.030 |
Why?
| | Intrinsic Factor | 2 | 2010 | 2 | 0.030 |
Why?
| | Renal Insufficiency | 2 | 1993 | 172 | 0.030 |
Why?
| | Larva | 1 | 2015 | 245 | 0.030 |
Why?
| | Isoelectric Focusing | 1 | 1994 | 30 | 0.030 |
Why?
| | Electrophoresis | 1 | 1994 | 31 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 387 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 468 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 220 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 95 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 78 | 0.030 |
Why?
| | Radioisotope Dilution Technique | 3 | 1988 | 14 | 0.030 |
Why?
| | Body Patterning | 1 | 2014 | 138 | 0.030 |
Why?
| | Chromatography, Affinity | 3 | 1988 | 80 | 0.030 |
Why?
| | Animal Feed | 2 | 2009 | 55 | 0.020 |
Why?
| | Myocardial Infarction | 2 | 2004 | 1216 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 335 | 0.020 |
Why?
| | Mammals | 1 | 2015 | 296 | 0.020 |
Why?
| | Neural Crest | 1 | 2014 | 129 | 0.020 |
Why?
| | Coronary Disease | 1 | 1996 | 381 | 0.020 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5426 | 0.020 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1994 | 138 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 339 | 0.020 |
Why?
| | Blood Glucose | 2 | 2016 | 2330 | 0.020 |
Why?
| | Litter Size | 1 | 2013 | 17 | 0.020 |
Why?
| | RNA, Viral | 2 | 2012 | 693 | 0.020 |
Why?
| | Dentate Gyrus | 1 | 2013 | 41 | 0.020 |
Why?
| | Hydrolysis | 1 | 2013 | 199 | 0.020 |
Why?
| | Avitaminosis | 2 | 2007 | 6 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2013 | 39 | 0.020 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1953 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1990 | 268 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 407 | 0.020 |
Why?
| | Tetrachloroethylene | 1 | 2012 | 4 | 0.020 |
Why?
| | Trichloroethylene | 1 | 2012 | 8 | 0.020 |
Why?
| | Tunicamycin | 1 | 2012 | 11 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2013 | 318 | 0.020 |
Why?
| | Ethylenes | 1 | 2012 | 17 | 0.020 |
Why?
| | Stroke Volume | 1 | 1996 | 654 | 0.020 |
Why?
| | Eating | 1 | 2015 | 388 | 0.020 |
Why?
| | Cell Differentiation | 2 | 2014 | 2045 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2012 | 104 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 1996 | 539 | 0.020 |
Why?
| | Lipotropic Agents | 1 | 2012 | 5 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2012 | 72 | 0.020 |
Why?
| | Neurologic Examination | 1 | 1992 | 132 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2012 | 75 | 0.020 |
Why?
| | HIV Seropositivity | 1 | 1993 | 119 | 0.020 |
Why?
| | Biodegradation, Environmental | 1 | 2012 | 87 | 0.020 |
Why?
| | Sarcoma, Kaposi | 1 | 1993 | 83 | 0.020 |
Why?
| | Embryo Loss | 1 | 2012 | 4 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 24 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.020 |
Why?
| | Chondrocytes | 1 | 2014 | 232 | 0.020 |
Why?
| | Hypoxanthine | 1 | 2012 | 11 | 0.020 |
Why?
| | Patient Selection | 1 | 1996 | 742 | 0.020 |
Why?
| | Postpartum Period | 1 | 2015 | 373 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2016 | 644 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2013 | 290 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 366 | 0.020 |
Why?
| | Catalase | 1 | 2012 | 133 | 0.020 |
Why?
| | Lipoproteins | 1 | 2013 | 166 | 0.020 |
Why?
| | S Phase | 1 | 2011 | 80 | 0.020 |
Why?
| | Radioligand Assay | 1 | 2011 | 36 | 0.020 |
Why?
| | Ferritins | 1 | 2011 | 70 | 0.020 |
Why?
| | Necrosis | 1 | 2012 | 244 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2011 | 120 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2013 | 264 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 31 | 0.020 |
Why?
| | Capsid Proteins | 1 | 2012 | 93 | 0.020 |
Why?
| | Microbiological Techniques | 1 | 2011 | 34 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2001 | 41 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 170 | 0.020 |
Why?
| | Epithelium | 1 | 2012 | 310 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2011 | 191 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 276 | 0.020 |
Why?
| | Breast Feeding | 1 | 2015 | 447 | 0.020 |
Why?
| | Chromatography, Ion Exchange | 2 | 1988 | 58 | 0.020 |
Why?
| | Ethanol | 1 | 1996 | 632 | 0.020 |
Why?
| | Chromatography, Gel | 2 | 1988 | 128 | 0.020 |
Why?
| | Nitrous Oxide | 1 | 1991 | 35 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 320 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 57 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 84 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 405 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 774 | 0.020 |
Why?
| | Transgenes | 1 | 2011 | 191 | 0.020 |
Why?
| | Neuroblastoma | 1 | 2012 | 174 | 0.020 |
Why?
| | Protein Conformation | 1 | 1994 | 935 | 0.020 |
Why?
| | Mitochondrial Diseases | 1 | 2011 | 92 | 0.020 |
Why?
| | Gastrins | 1 | 1990 | 8 | 0.020 |
Why?
| | Serum Albumin | 1 | 2011 | 144 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 178 | 0.020 |
Why?
| | Peroxidase | 1 | 2011 | 168 | 0.020 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2010 | 7 | 0.020 |
Why?
| | Placebos | 2 | 2005 | 193 | 0.020 |
Why?
| | Renal Dialysis | 1 | 1995 | 465 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 539 | 0.020 |
Why?
| | Hypertension | 1 | 1999 | 1273 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 324 | 0.020 |
Why?
| | Macromolecular Substances | 2 | 1988 | 219 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 1990 | 70 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 120 | 0.020 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2010 | 19 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2004 | 2664 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 153 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1990 | 15 | 0.020 |
Why?
| | Bilirubin | 1 | 1990 | 99 | 0.020 |
Why?
| | Monocytes | 1 | 2013 | 536 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2137 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 626 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 505 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 961 | 0.020 |
Why?
| | Aorta | 1 | 2013 | 439 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 532 | 0.020 |
Why?
| | Purines | 1 | 2011 | 187 | 0.020 |
Why?
| | Dairying | 1 | 2009 | 12 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 1991 | 567 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2010 | 45 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 743 | 0.020 |
Why?
| | Fear | 1 | 2013 | 367 | 0.020 |
Why?
| | Hemostasis | 1 | 2010 | 98 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 751 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 119 | 0.020 |
Why?
| | Nigeria | 1 | 2009 | 24 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 373 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2011 | 313 | 0.020 |
Why?
| | Burkitt Lymphoma | 1 | 1989 | 62 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 422 | 0.020 |
Why?
| | Osteosarcoma | 1 | 1989 | 77 | 0.020 |
Why?
| | Acetylcarnitine | 1 | 1988 | 6 | 0.020 |
Why?
| | Muscles | 1 | 1990 | 332 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 1134 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 689 | 0.020 |
Why?
| | Peroxides | 1 | 2008 | 19 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2012 | 369 | 0.020 |
Why?
| | Bacteria | 1 | 2015 | 897 | 0.020 |
Why?
| | Microchemistry | 1 | 1988 | 19 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 77 | 0.020 |
Why?
| | Isoleucine | 1 | 1988 | 15 | 0.020 |
Why?
| | Silicon | 1 | 1988 | 21 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 1988 | 39 | 0.020 |
Why?
| | Health Status Disparities | 1 | 2011 | 321 | 0.020 |
Why?
| | Catalytic Domain | 1 | 2009 | 235 | 0.020 |
Why?
| | Multivariate Analysis | 2 | 2002 | 1544 | 0.020 |
Why?
| | Ethiopia | 1 | 2008 | 44 | 0.020 |
Why?
| | Predictive Value of Tests | 3 | 2000 | 2129 | 0.020 |
Why?
| | Tritium | 1 | 1988 | 68 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1081 | 0.020 |
Why?
| | Thiolester Hydrolases | 1 | 1988 | 13 | 0.020 |
Why?
| | Haplotypes | 1 | 2010 | 498 | 0.020 |
Why?
| | Ileum | 1 | 2009 | 112 | 0.020 |
Why?
| | Zea mays | 1 | 2008 | 43 | 0.020 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 198 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2011 | 566 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 1994 | 631 | 0.020 |
Why?
| | Valine | 1 | 1988 | 82 | 0.020 |
Why?
| | Pyrimidines | 1 | 2011 | 520 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2008 | 245 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1992 | 608 | 0.020 |
Why?
| | Fibrosis | 1 | 2010 | 551 | 0.020 |
Why?
| | Embryonic Development | 1 | 2008 | 125 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 392 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2007 | 27 | 0.020 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2007 | 4 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2007 | 160 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 772 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 694 | 0.020 |
Why?
| | Infusions, Intravenous | 2 | 2003 | 427 | 0.020 |
Why?
| | Prenatal Care | 1 | 2009 | 312 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2006 | 72 | 0.020 |
Why?
| | Creatine | 1 | 2007 | 63 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2009 | 269 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 1998 | 147 | 0.020 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2006 | 31 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 296 | 0.010 |
Why?
| | von Willebrand Diseases | 1 | 2006 | 28 | 0.010 |
Why?
| | Rabbits | 1 | 2007 | 651 | 0.010 |
Why?
| | Public Health | 1 | 2011 | 573 | 0.010 |
Why?
| | Gene Frequency | 1 | 2007 | 483 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2008 | 322 | 0.010 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2010 | 419 | 0.010 |
Why?
| | Dicarboxylic Acids | 1 | 1985 | 13 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 531 | 0.010 |
Why?
| | Muscular Diseases | 1 | 2006 | 108 | 0.010 |
Why?
| | Edible Grain | 1 | 2005 | 48 | 0.010 |
Why?
| | Croatia | 1 | 2005 | 4 | 0.010 |
Why?
| | Transaminases | 1 | 2005 | 22 | 0.010 |
Why?
| | Dipeptides | 1 | 2005 | 56 | 0.010 |
Why?
| | HIV-1 | 2 | 2001 | 905 | 0.010 |
Why?
| | Creatine Kinase | 1 | 2005 | 72 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 88 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.010 |
Why?
| | RNA Interference | 1 | 2006 | 473 | 0.010 |
Why?
| | New York City | 1 | 2004 | 89 | 0.010 |
Why?
| | tert-Butylhydroperoxide | 1 | 2004 | 9 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1261 | 0.010 |
Why?
| | Metals | 1 | 1985 | 140 | 0.010 |
Why?
| | Apolipoprotein E4 | 1 | 2004 | 42 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 883 | 0.010 |
Why?
| | Neurons | 1 | 2013 | 1647 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2011 | 17269 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1614 | 0.010 |
Why?
| | Psychological Tests | 1 | 2004 | 132 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2005 | 420 | 0.010 |
Why?
| | Hemostasis, Surgical | 1 | 2003 | 25 | 0.010 |
Why?
| | Depression | 1 | 2013 | 1573 | 0.010 |
Why?
| | Hepatocytes | 1 | 2004 | 224 | 0.010 |
Why?
| | Myelin Sheath | 1 | 2005 | 169 | 0.010 |
Why?
| | Inactivation, Metabolic | 1 | 2002 | 9 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2004 | 175 | 0.010 |
Why?
| | Colorado | 1 | 1992 | 4572 | 0.010 |
Why?
| | Enzyme Stability | 1 | 2002 | 73 | 0.010 |
Why?
| | Pemetrexed | 1 | 2002 | 40 | 0.010 |
Why?
| | Cricetulus | 1 | 2002 | 115 | 0.010 |
Why?
| | Citrate (si)-Synthase | 2 | 1993 | 53 | 0.010 |
Why?
| | Drug Contamination | 1 | 2002 | 53 | 0.010 |
Why?
| | Autoantibodies | 1 | 2010 | 1512 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 625 | 0.010 |
Why?
| | Carcinoma | 1 | 2004 | 224 | 0.010 |
Why?
| | Physical Chromosome Mapping | 1 | 2001 | 20 | 0.010 |
Why?
| | Brain Death | 1 | 2002 | 59 | 0.010 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2001 | 36 | 0.010 |
Why?
| | Hepatomegaly | 1 | 2001 | 4 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2007 | 779 | 0.010 |
Why?
| | Vasodilation | 1 | 2005 | 521 | 0.010 |
Why?
| | Transcription Factors | 1 | 2010 | 1733 | 0.010 |
Why?
| | Radiography | 1 | 2004 | 852 | 0.010 |
Why?
| | Treatment Refusal | 1 | 2002 | 98 | 0.010 |
Why?
| | Hypertension, Renal | 1 | 2001 | 15 | 0.010 |
Why?
| | Computational Biology | 1 | 2006 | 687 | 0.010 |
Why?
| | Coffee | 1 | 2001 | 15 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2003 | 159 | 0.010 |
Why?
| | Tea | 1 | 2001 | 17 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 2007 | 711 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 782 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 210 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1710 | 0.010 |
Why?
| | Chromatography, Gas | 1 | 2000 | 31 | 0.010 |
Why?
| | Cell Survival | 1 | 2004 | 1094 | 0.010 |
Why?
| | Bone Marrow Diseases | 1 | 2000 | 20 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 509 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2002 | 343 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2000 | 112 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2007 | 831 | 0.010 |
Why?
| | Platelet Count | 1 | 2000 | 96 | 0.010 |
Why?
| | Kynurenine | 1 | 2000 | 103 | 0.010 |
Why?
| | Ultrasonography | 1 | 2004 | 784 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2000 | 316 | 0.010 |
Why?
| | Probability | 1 | 2000 | 310 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2000 | 432 | 0.010 |
Why?
| | Hypersplenism | 1 | 1999 | 9 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2000 | 449 | 0.010 |
Why?
| | Tryptophan | 1 | 2000 | 175 | 0.010 |
Why?
| | Zimbabwe | 1 | 1999 | 76 | 0.010 |
Why?
| | Anemia, Aplastic | 1 | 1999 | 42 | 0.010 |
Why?
| | Life Style | 1 | 2001 | 483 | 0.010 |
Why?
| | Chromatography, DEAE-Cellulose | 2 | 1988 | 10 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2915 | 0.010 |
Why?
| | Carbon Radioisotopes | 2 | 1988 | 29 | 0.010 |
Why?
| | Viral Load | 1 | 2000 | 528 | 0.010 |
Why?
| | Indicators and Reagents | 2 | 1988 | 106 | 0.010 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2000 | 261 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 857 | 0.010 |
Why?
| | Demyelinating Diseases | 1 | 1998 | 84 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2000 | 1046 | 0.010 |
Why?
| | Drug Overdose | 1 | 2002 | 374 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2001 | 518 | 0.010 |
Why?
| | Genes | 1 | 1996 | 226 | 0.010 |
Why?
| | Theophylline | 1 | 1996 | 41 | 0.010 |
Why?
| | Leukemia | 1 | 1999 | 246 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1996 | 4 | 0.010 |
Why?
| | Thymine Nucleotides | 1 | 1996 | 19 | 0.010 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 1996 | 48 | 0.010 |
Why?
| | Diet Surveys | 1 | 1996 | 90 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1996 | 89 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1040 | 0.010 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1996 | 130 | 0.010 |
Why?
| | Bronchodilator Agents | 1 | 1996 | 187 | 0.010 |
Why?
| | Age of Onset | 1 | 1996 | 554 | 0.010 |
Why?
| | Autopsy | 1 | 1994 | 95 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1994 | 165 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2003 | 964 | 0.010 |
Why?
| | Cell Division | 1 | 1996 | 753 | 0.010 |
Why?
| | Chromatography | 1 | 1993 | 27 | 0.010 |
Why?
| | Belgium | 1 | 1993 | 11 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 365 | 0.010 |
Why?
| | Massachusetts | 1 | 1994 | 180 | 0.010 |
Why?
| | Netherlands | 1 | 1993 | 82 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2002 | 2355 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1993 | 103 | 0.010 |
Why?
| | Germany | 1 | 1993 | 138 | 0.010 |
Why?
| | Swine | 1 | 1996 | 833 | 0.010 |
Why?
| | Blood Chemical Analysis | 1 | 1993 | 110 | 0.010 |
Why?
| | Culture Media | 1 | 1993 | 163 | 0.010 |
Why?
| | Borohydrides | 1 | 1991 | 1 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1991 | 8 | 0.010 |
Why?
| | Plasma | 1 | 1993 | 225 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 1991 | 91 | 0.010 |
Why?
| | Glutamate Dehydrogenase | 1 | 1990 | 4 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 2207 | 0.010 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 1990 | 49 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1990 | 66 | 0.010 |
Why?
| | Molecular Structure | 1 | 1991 | 498 | 0.000 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 1994 | 389 | 0.000 |
Why?
| | Glucose | 1 | 1994 | 1039 | 0.000 |
Why?
| | Light | 1 | 1991 | 406 | 0.000 |
Why?
| | Erythrocyte Indices | 1 | 1988 | 33 | 0.000 |
Why?
| | Hypesthesia | 1 | 1988 | 21 | 0.000 |
Why?
| | Ataxia | 1 | 1988 | 69 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1990 | 718 | 0.000 |
Why?
| | Intestines | 1 | 1990 | 357 | 0.000 |
Why?
| | Celiac Disease | 1 | 1990 | 310 | 0.000 |
Why?
| | Algorithms | 1 | 1994 | 1855 | 0.000 |
Why?
| | Models, Theoretical | 1 | 1989 | 579 | 0.000 |
Why?
| | Chemistry | 1 | 1985 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1985 | 81 | 0.000 |
Why?
| | Proteins | 1 | 1990 | 1020 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1795 | 0.000 |
Why?
|
|
Stabler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|